SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,218,000 | +24.8% | 81,284 | +1.4% | 0.00% | +100.0% |
| Q1 2016 | $976,000 | -13.9% | 80,150 | +12.5% | 0.00% | -50.0% |
| Q4 2015 | $1,134,000 | -10.4% | 71,273 | -13.6% | 0.00% | 0.0% |
| Q3 2015 | $1,266,000 | -73.9% | 82,532 | -58.7% | 0.00% | -71.4% |
| Q2 2015 | $4,855,000 | -14.8% | 199,712 | -18.5% | 0.01% | -12.5% |
| Q1 2015 | $5,696,000 | -13.1% | 244,970 | -6.1% | 0.01% | -20.0% |
| Q4 2014 | $6,551,000 | -19.4% | 260,886 | -0.1% | 0.01% | -23.1% |
| Q3 2014 | $8,124,000 | +22.8% | 261,212 | +2.1% | 0.01% | +18.2% |
| Q2 2014 | $6,615,000 | +10.5% | 255,775 | -0.1% | 0.01% | 0.0% |
| Q1 2014 | $5,987,000 | -7.4% | 256,143 | +0.5% | 0.01% | -8.3% |
| Q4 2013 | $6,466,000 | +30.5% | 254,763 | +5.9% | 0.01% | +20.0% |
| Q3 2013 | $4,956,000 | +217.5% | 240,537 | +229.4% | 0.01% | +233.3% |
| Q2 2013 | $1,561,000 | – | 73,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |